Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Recent Patents on Biotechnology|February 25, 2012
Recent patents on alphavirus protein expression and vector productionAlejandro Aranda, Marta Ruiz-Guillen, Jose I Quetglas, et al.Virus Research|August 10, 2010
Alphavirus vectors for cancer therapyJose I Quetglas, Marta Ruiz-Guillen, Alejandro Aranda, et al.Journal of Virology|November 25, 2011
Small rho GTPases and cholesterol biosynthetic pathway intermediates in African swine fever virus infectionJose I Quetglas, Bruno Hernáez, Inmaculada Galindo, et al.New Biotechnology|March 2, 2010
A novel system for the production of high levels of functional human therapeutic proteins in stable cells with a Semliki Forest virus noncytopathic vectorErkuden Casales, Alejandro Aranda, Jose I Quetglas, et al.Plos One|November 17, 2012
Antibodies against Marinobacter algicola and Salmonella typhimurium flagellins do not cross-neutralize TLR5 activationRaul Terron-Exposito, Benoit Dudognon, Inmaculada Galindo, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2013
Eradication of liver-implanted tumors by Semliki Forest virus expressing IL-12 requires efficient long-term immune responsesJose I Quetglas, Juan R Rodriguez-Madoz, Jaione Bezunartea, et al.Molecular Cancer|December 17, 2015
Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer modelEstanislao Nistal-Villan, Maria Bunuales, Joanna Poutou, et al.Cellular and Molecular Life Sciences : CMLS|April 28, 2016
Capsid-deficient alphaviruses generate propagative infectious microvesicles at the plasma membraneMarta Ruiz-Guillen, Evgeni Gabev, Jose I Quetglas, et al.Cancer Research|December 21, 2014
Strict requirement for vector-induced type I interferon in efficacious antitumor responses to virally encoded IL12Ignacio Melero, Jose I Quetglas, Mercedes Reboredo, et al.Oncoimmunology|March 5, 2016
Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanismSara Labiano, Asis Palazón, Elixabet Bolaños, et al.Pageof 2